Home › ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development
 

Keywords :   


ForteBio Launches Dip And Read Anti-Human Fab-CH1 Biosensor To Accelerate Human Biotherapeutic Drug Development

2013-01-09 18:00:00| drugdiscoveryonline News Articles

ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, recently announced the launch of its Dip and Read Anti-Human Fab-CH1 biosensor

Tags: read development human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Potential Storm Surge Flooding Map
06.10Hurricane Milton Probabilistic Storm Surge Graphics
06.10Hurricane Milton Graphics
06.10Hurricane Milton Forecast Discussion Number 6
06.10Hurricane Milton Wind Speed Probabilities Number 6
06.10Hurricane Milton Public Advisory Number 6
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Hurricane Kirk Graphics
More »